ELTX Elicio Therapeutics Inc.

  1. Stocks
  2. Healthcare
  3. NASDAQ: ELTX

Price (delayed)

$13.96

Market cap

$266.44M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.4

Enterprise value

$265.83M

?
Relative Growth: Rel. Growth: 13
Relative Strength: Rel. Strength: 75
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 7
Highlights
Elicio Therapeutics's EPS has increased by 39% YoY and by 7% from the previous quarter
The net income has increased by 22% year-on-year
The quick ratio has increased by 24% YoY but it has decreased by 10% QoQ
ELTX's equity has dropped by 188% since the previous quarter and by 116% year-on-year
ELTX's debt has soared by 148% YoY
Sector: Healthcare
Industry: Biotechnology
Peers: OLMA OMER VIVS ORIC

Key stats

What are the main financial stats of ELTX

ELTX stock price

How has the Elicio Therapeutics stock price performed over time
Intraday
11.41%
1 week
31.57%
1 month
29.62%
1 year
72.35%
YTD
75.38%
QTD
30.59%

Financial performance

How have Elicio Therapeutics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$37.58M
Net income
-$40.19M
Gross margin
N/A
Net margin
N/A
The net income has increased by 22% year-on-year
The operating income rose by 17% year-on-year

Price vs fundamentals

How does ELTX's price correlate with its fundamentals

Growth

What is Elicio Therapeutics's growth rate over time

Valuation

What is Elicio Therapeutics stock price valuation
P/E
N/A
P/B
N/A
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Elicio Therapeutics's EPS has increased by 39% YoY and by 7% from the previous quarter
ELTX's equity has dropped by 188% since the previous quarter and by 116% year-on-year

Efficiency

How efficient is Elicio Therapeutics business performance
The ROE has plunged by 181% from the previous quarter
ELTX's return on invested capital is up by 19% since the previous quarter and by 11% year-on-year
The company's return on assets rose by 19% YoY but it fell by 7% QoQ

Dividends

What is ELTX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ELTX.

Financial health

How did Elicio Therapeutics financials performed over time
The total assets is 6% smaller than the total liabilities
ELTX's total liabilities is up by 25% YoY
The quick ratio has increased by 24% YoY but it has decreased by 10% QoQ
ELTX's equity has dropped by 188% since the previous quarter and by 116% year-on-year
ELTX's debt has soared by 148% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.